CD Biosynsis offers high-precision Synechococcus spp. Base Editing Services, providing a revolutionary DNA-double-strand-break-free (DSB-free) method for single-nucleotide substitutions. In polyploid cyanobacteria like S. elongatus PCC 7942 and S. sp. PCC 7002, traditional CRISPR-Cas9 often leads to cell toxicity or genomic instability due to multiple chromosomal breaks. Base Editing (BE) bypasses these issues by directly converting one base pair to another (e.g., C:G to T:A or A:T to G:C) at specific genomic coordinates. This platform is ideal for engineering photosynthetic protein domains, introducing herbicide resistance as a selectable marker, or fine-tuning metabolic enzymes without the unpredictable indels or lengthy segregation cycles associated with standard CRISPR tools.
Our base editing solutions are specifically optimized for the cyanobacterial intracellular environment. By utilizing catalytically impaired "nuclease-dead" Cas9 (dCas9) or nickase Cas9 (nCas9) fused to specialized deaminases, we achieve high-efficiency nucleotide conversion within a narrow "editing window." This capability enables "scarless" point mutations that were previously difficult to achieve due to the low efficiency of Homology-Directed Repair (HDR) in cyanobacteria. Whether you are performing functional studies on the circadian clock proteins or optimizing the catalytic sites of enzymes involved in the Calvin cycle, our base editing services provide the precision and genomic integrity required for advanced synthetic biology.
Get a QuoteBase editing in Synechococcus allows for the introduction of specific amino acid changes at the native locus without altering the surrounding genomic context. This is achieved by targeting a deaminase to a specific DNA site via a guide RNA (gRNA). Once localized, the deaminase converts the target base (C or A) into a different base, which the cell's replication or mismatch repair machinery then fixes into a permanent mutation. This approach is vital for engineering strains with enhanced industrial properties, such as improved tolerance to high-intensity light or the development of "non-GMO" appearing point mutants.
Our platform uses codon-optimized base editors specifically designed for the GC content and transcriptional signals of Synechococcus. We account for the polyploid nature of cyanobacteria by selecting editor variants that achieve high conversion rates across all chromosomal copies, ensuring that the desired phenotype is fully manifested in the population. By minimizing "bystander" editing—unwanted mutations in adjacent bases—we deliver strains with unprecedented genetic fidelity, moving cyanobacterial biotechnology from random mutagenesis to predictive, site-specific engineering.
We provide a range of base editing tools tailored to different types of nucleotide conversions and research objectives in various Synechococcus strains.
Mechanism
Utilizes a cytidine deaminase (e.g., APOBEC) to convert Cytosine to Uracil, resulting in a C-to-T transition after DNA replication.
Gene Inactivation
Application of iSTOP technology to convert sense codons into premature stop codons (TAG, TAA, TGA), enabling gene knockouts without the toxicity of DNA breaks.
Mechanism
Utilizes an evolved adenosine deaminase (e.g., TadA) to convert Adenine to Inosine, which is read as Guanine, resulting in an A-to-G transition.
Residue Swapping
Ideal for altering specific amino acid residues in enzymes involved in bioplastic (PHB) synthesis or pigment pathways to modify activity.
Herbicide Resistance
Targeting genes like psbA or gyrA to introduce precise mutations that confer resistance to inhibitors, serving as clean, selectable markers.
Regulatory Editing
Modifying -10 or -35 boxes in promoters to tune the expression levels of endogenous genes without introducing large-scale disruptions.
Our rigorous workflow ensures high-purity strains with full genomic verification of the target edit across all genome copies.
1. Computational Design
2. Tool Assembly & Prep
3. Transformation & Screening
4. Verification & Delivery
Identification of the target nucleotide within the optimal editing window (typically 5-8 bp within the gRNA). Design of gRNAs and codon optimization of the editor for Synechococcus.
Synthesis of base editor vectors (integrative at Neutral Sites or replicative plasmids). Preparation of competent cells or conjugation partners (e.g., E. coli HB101).
Verification: Targeted NGS or Sanger sequencing of the locus to quantify conversion efficiency and verify homozygosity. Phenotypic Validation: Assessment of growth and target traits. Delivery of cryopreserved strains.
DSB-Free Safety
Avoids the toxicity and genomic rearrangements often caused by multiple double-strand breaks in polyploid cyanobacterial hosts.
Scarless Modifications
Enables the introduction of precise point mutations without leaving behind foreign DNA or selection markers, resulting in "clean" edited strains.
High Efficiency
Our optimized base editors achieve high-frequency conversion, simplifying the isolation of mutants even in polyploid backgrounds.
Optimized Toolkits
Access to a library of base editors codon-optimized specifically for Synechococcus to ensure maximal nuclear expression and activity.
Technical insights for your Synechococcus base editing project.
Contact Us1. How does base editing differ from standard CRISPR-Cas9 in Synechococcus?
Standard CRISPR creates double-strand breaks (DSBs) which can be lethal or lead to random indels. Base editing chemically converts one base to another without breaking the DNA backbone, making it much safer and more precise.
2. What is the typical "editing window" for these base editors?
The activity window is usually 5-8 bp within the gRNA sequence. We design gRNAs to place your target base precisely within this zone for optimal conversion.
3. Can base editing be used to create gene knockouts?
Yes. By converting a sense codon into a premature stop codon (e.g., CAA to TAA), we can achieve gene inactivation without the indels associated with DSBs.
4. How do you handle the polyploidy of Synechococcus PCC 7942?
We select editors with high conversion efficiencies and utilize selective pressure to ensure that the edited base is segregated and fixed across all genomic copies.
5. How do you confirm the success of the base edit?
We perform targeted Sanger sequencing or Next-Generation Sequencing (NGS). A single peak (for Sanger) or ~100% read count (for NGS) at the target position confirms homozygous editing.
6. Is the base edit permanent and stable?
Yes. Once the chemical conversion is fixed by the cell's DNA repair and replication machinery, the mutation is as stable as any other genomic sequence across generations.
7. Can you perform multiplexed base editing?
Yes, we can deliver multiple gRNAs to target several sites simultaneously, enabling the engineering of complex protein domains or multiple regulatory regions.
8. What is the typical turnaround time for a project?
A standard base editing project from design to verified homozygous strain delivery typically takes 10 to 14 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.